Perminova, Inc., an innovator in affordable, flexible web-hosted Electronic Health Record (EHR) systems, and the leading provider of comprehensive web-hosted surgery information management systems, received the endorsement of renowned Cardiologist Dr. Andrea Natale to pursue the acquisition of Perminova’s CardioSure Application Suite™.
Dr. Andrea Natale is a leading pioneer in the field of atrial fibrillation (“AF” or “A-Fib”) ablation; he pioneered a new circumferential ultrasound vein-ablation system to correct atrial fibrillation and performed the procedure on the world’s first five patients. He also developed some of the current catheter-based cures for atrial fibrillation and was the first electrophysiologist in the nation to perform percutaneous epicardial radiofrequency ablation, which is a treatment for people who fail conventional ablation.
Dr. Natale received the Cleveland Clinic Innovator Award for Innovation in 2004, 2005 and 2006; in 2006, he was named to the Food and Drug Administration’s Task Force on Atrial Fibrillation.
“I am pleased with the ease of its use and how intuitive it is. I can foresee the system’s potential for the EP laboratory as well as the EP practice office,” noted Dr. Andrea Natale. “My interest is to use the system to link my EP labs and practice office in TX and CA. I will definitely advocate its implementation in other places where I have clinical appointments”.
Dr. Natale currently holds senior positions at some of the nation’s most prestigious healthcare organizations, including: Senior Medical Director of Electrophysiology at the California Pacific Medical Center “CPMC” in San Francisco, CA; Executive Medical Director at Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, Texas; Director of Interventional Cardiac Electrophysiology at Scripps Clinic, in La Jolla, CA; Consulting Professor for the division of Cardiology at Stanford University in Stanford, CA; and Clinical Associate Professor of Medicine at Case Western Reserve University in Cleveland OH.
“We are very proud that Dr. Natale has selected our EP Module to enhance his clinical practices” said Robert Cass co-founder, and CEO of Perminova. “His endorsement and collaboration will help us fulfill our commitment to delivering the highest quality patient care through the use of our solutions.”